Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

IM Cannabis Corp (CSE: IMCC )

3.740 UNCHANGED
Official Closing Price Updated: 3:23 PM EST, Nov 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IM Cannabis Corp

< Previous 1 2 Next >
IM Cannabis: 66% Revenue Growth In Germany, Narrows EBITDA Loss In Q3
International medical cannabis company IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) announced on Thursday its financial results for the third quarter ended Sept. 30, 2024. The company reported revenue... 
Via Benzinga
Topics Cannabis Economy
Exposures Cannabis Supply Chain
Canopy Growth And Other Top Cannabis Companies To Report Earnings: Will Results Get Pot Stocks On Track Following Post-Election Dip?
Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) will report the second quarter of fiscal year 2025 ended Sept. 30, before financial markets open on Friday, Nov. 8, 2024. IM Cannabis Corp. (CSE:... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
The Ever-Evolving Cannabis Industry: These Are Latest Leadership Changes You Should Know About
The U.S. Hemp Roundtable made headlines in early September as its board of directors welcomed two distinguished leaders from the hemp beverage sector to its officer ranks. New York's chief equity... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
IM Cannabis' $1.6M Non-Brokered Private Placement Offering, Here's What Investors Need To Know
Medical cannabis company with operations in Israel and Germany, IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC), intends to undertake a non-brokered private placement offering of up to $1,613,000 through... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
How Cannabis Legalization In Germany Boosted This Company's Revenue, Will Spain's Medical Marijuana Framework Do The Same?
Spain's Ministry of Health revealed this week a draft royal decree for public consultation, outlining the suggested regulations for prescribing cannabis-based medications, reported Business of... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
IM Cannabis Soars: German Sales Surge 200% In First 3 Months Post-Legalization, Q2 Revenue Up 12% YoY
The company, announced its financial results Wednesday for the second quarter ended June 30, 2024, revealing a 12% year-over-year increase in revenue to CA$14.8 million in the second quarter of 2023.... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
IM Cannabis, Organigram And Other Hot Cannabis Stocks Soon To Report Earnings, What Investors Need To Know Now
Medical cannabis company IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC), with operations in Israel and Germany, will report operational and financial results for the second quarter of 2024 ended June 30,... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
IM Cannabis Announces Major Share Consolidation Plan: What Investors Need To Know
IM Cannabis announces a share consolidation effective July 12, aiming to enhance marketability and streamline shares. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Global Weed Business: Flora Buys Australian Vaporizers As IM Cannabis Doubles Down On Germany
Lifeist Wellness Inc. (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF) said on Wednesday the sale of Australian Vaporizers Pty Ltd., its wholly owned Australian subsidiary to Flora Growth Corp. (NASDAQ:... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
IM Cannabis Doubles Down On Germany Following Legalization Policy Change, Reports YoY Drop In Q1 Gross Profit And Revenue
IM Cannabis reported a 13% sequential increase in revenue for the three months ended March 31, 2024, hitting CA$10.7 million ($7.8 million). That is, however, a 4% decrease compared to the same quarter... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Avant Brands Bolsters International Growth in German Cannabis Market Through Partnership with IMC
Via ACCESSWIRE
IM Cannabis' Q4 Revenue: Gross Profit Drops Due To Negative Impact Of Israel-Hamas War, Sees Germany As Growth Opportunity
IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) announced on Thursday its financial and operational results for the year ended Dec. 2023. The Toronto-headquartered medical cannabis company with a focus on... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
IM Cannabis Stock Drops On Q2 Earnings, CEO Touts Strategic Decisions That Led To 'Sustainable Profitability'
IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) reported its second-quarter financial results on Tuesday for the period ending June 30, 2023. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Avant Brands and IM Cannabis Announce the Launch of BLK MKT in Israel
Via ACCESSWIRE
IM Cannabis announces Focus Medical's Import of 400 Kilograms of Premium-Indoor-Grown Dried Cannabis from Canada to Israel
The successful import demonstrates the strength of the IM Cannabis global supply chain and business model TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / January 19, 2022 / IM Cannabis Corp. (the... 
From IM Cannabis Corp.
Via AccessWire
Topics Cannabis Economy
Exposures Cannabis Supply Chain
IM Cannabis Corp. Appoints Rinat Efrima as New Chief Executive Officer of IMC Holdings, the Company’s Israeli Subsidiary
Oren Shuster remains Chief Executive Officer and Director of IM Cannabis Corp.; other managerial changes include the promotion of Yael Harrosh to Chief Legal and Operations Officer of IM Cannabis Corp.... 
From IM Cannabis Corp.
Via AccessWire
Topics Cannabis
Exposures Cannabis
IM Cannabis to Launch WAGNERS Brand in Germany
IM Cannabis expects to export premium, indoor-grown Canadian cannabis in 2022 to the rapidly evolving German medical cannabis market TORONTO, ON, GLIL YAM, ISRAEL and BAD OLDESLOE, GERMANY / ACCESSWIRE... 
From IM Cannabis Corp.
Via AccessWire
Topics Cannabis
Exposures COVID-19 Cannabis
IM Cannabis To Buy Jerusalem-Based Medical Marijuana Pharmacy For $4.9M In Cash And Stock
IM Cannabis Corp. (CSE:IMCC), (NASDAQ: 
Via Benzinga
Topics Cannabis
Exposures Cannabis
IM Cannabis to Acquire Oranim, Jerusalem's Leading Medical Cannabis Pharmacy
Transaction positions IM Cannabis as one of the largest retailers of medical cannabis in Israel; Retail segment combined annualized revenue of approximately $44 million Oranim's trailing 12-month... 
From IM Cannabis Corp.
Via AccessWire
Topics Cannabis
Exposures Cannabis
IM Cannabis To Debut WAGNERS Brand In Israel After Receiving Regulatory Approval
IM Cannabis Corp. (CSE:IMCC) (NASDAQ: 
Via Benzinga
Topics Cannabis
Exposures Cannabis
IM Cannabis Announces Focus Medical's Receipt of Israeli Ministry of Health Import Permit; Plans to Launch WAGNERS Brand in Israel
IM Cannabis' popular recreational cannabis brand WAGNERS will be available in Israel in 2022, enhancing IM Cannabis' presence in the market TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / November 29,... 
From IM Cannabis Corp.
Via AccessWire
Topics Cannabis
Exposures COVID-19 Cannabis
IM Cannabis Announces Fourth Installment of Shares in Connection with the Panaxia Transaction
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / November 18, 2021 / IM Cannabis Corp. (the "Company" or "IM Cannabis") (CSE:IMCC)(NASDAQ:IMCC), a leading medical and adult-use recreational cannabis... 
From IM Cannabis Corp.
Via AccessWire
Topics Cannabis Law Enforcement
Exposures COVID-19 Cannabis Legal
IM Cannabis Announces Third Quarter 2021 Financial Results and Provides Outlook and Business Update
Q3 2021 revenues of $14.4 million; a 30% increase from Q2 2021 Gross margin improved to 20% from 5.4% in Q2 2021; expected to increase further in Q4 and into 2022 Canadian recreational brands WAGNERS... 
From IM Cannabis Corp.
Via AccessWire
Topics Cannabis Law Enforcement
Exposures COVID-19 Cannabis Legal
IMC Announces Third Installment of Shares in Connection with the Panaxia Transaction
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / October 20, 2021 / IM Cannabis Corp. (the "Company" or "IM Cannabis") (CSE:IMCC, NASDAQ:IMCC), a leading medical and adult-use recreational cannabis... 
From IM Cannabis Corp.
Via AccessWire
Topics Cannabis Law Enforcement
Exposures COVID-19 Cannabis Legal
IMC Provides Further Details on Panaxia Transaction
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / September 8, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC) (NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use... 
From IM Cannabis Corp.
Via AccessWire
Topics Cannabis Intellectual Property Law Enforcement
Exposures COVID-19 Cannabis Intellectual Property
IM Cannabis Announces Q2 2021 Financial Results and Signing of Definitive Agreement to Acquire Vironna Pharm, Accelerating its Vertical Integration Strategy in Israel
Q2 2021 revenues of $11.1 million, a 27% increase from Q1 2021 Acquisition of Vironna pharmacy positions IMC in rapidly growing Arab consumer segment in Israel Following strong start to Q3 across each... 
From IM Cannabis Corp.
Via AccessWire
Topics Cannabis Intellectual Property Law Enforcement
Exposures COVID-19 Cannabis Intellectual Property
IMC Partners with Leading US Brand to Launch cbdMD Products in Israel and Provides Further Details on Panaxia Transaction
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / August 9, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC, NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use... 
From IM Cannabis Corp.
Via AccessWire
Topics Cannabis Law Enforcement
Exposures COVID-19 Cannabis Legal
IMC Announces Results of its Annual General and Special Meeting of Shareholders
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / August 3, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC), (NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use... 
From IM Cannabis Corp.
Via AccessWire
Topics Cannabis
Exposures Cannabis
IMC Accelerates its Israeli Retail Position through Acquisition of Leading Retailer and Distributor Pharm Yarok and Rosen High Way
- Strategically located, best in class retailer with approximately CAD$8 million in annualized revenue - Purchase price of CAD$4.6 million TORONTO, ON, GLIL YAM and NATANYA, ISRAEL / ACCESSWIRE / July... 
From IM Cannabis Corp.
Via AccessWire
Topics Cannabis Intellectual Property Law Enforcement
Exposures COVID-19 Cannabis Intellectual Property
IM Cannabis Provides Update on German Operations and Financial Outlook
TORONTO, ON, BAD OLDESLOE, GERMANY, and GLIL YAM, ISRAEL / ACCESSWIRE / July 23, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC) (NASDAQ:IMCC), a multi-country operator ("MCO") in the... 
From IM Cannabis Corp.
Via AccessWire
Topics Cannabis Law Enforcement
Exposures COVID-19 Cannabis Legal
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.